Saturday, March 11, 2017

Does Insulin Potentiation Therapy work?

The following is a rebuttal to self proclaimed "medical writters" about Insulin Potentiation Therapy IPT or IPTLD.

I will start by sharing a comment made by R.W. Moss about chemotherapy (extract reproduced from a public source at “RM: Chemotherapy is machismo practiced to the N'th degree. It is a war in which you are the battleground, lucky you, I mean you have to treat your body better than that. The folks that bring you the toxic chemicals that cause the cancer are then kind enough to bring you toxic chemicals that allegedly…..”

 Yes IPT/IPTLD works, it is a treatment alternative for lasting and successful outcomes. #InsulinPotentiationTherapy #IPT© or #IPTLD®, it is a metabolic supported chemotherapy. It involves fasting, insulin and chemotherapy. This is not a miracle product or the cure that is hidden from you. It is a safe treatment alternative. Not all patients will benefit. Consult your case: .

I have undertaken to write this rebuttal because insulin potentiation therapy (IPT/ IPTLD) has helped multitudes of people with cancer who had already undergone the conventional route of surgery, chemotherapy and radiation and whose oncology team explained that there was “nothing else we can do.” I have personally had hundreds of these types of patients come to our center and, guess what? There was and is something that can be done to be restored to health.
It is clear that the self called "medical writers" and editors R.Baratz, RW Moss, J Jones, have not studied the protocols or the science behind insulin potentiation therapy (IPT/IPTLD). Their position regarding IPT/IPTLD as reflected in their writings posted on their Blogs has either evolved out of hearsay or their imagination, not honest research into the subject matter, which indicates that they are attempting to alter people’s opinion regarding this chemotherapy delivery system by ‘reference to “authority,” rather than by utilizing factual information in an effort to inform or educate. The following is a definition of this fallacious way of arguing utilized by Dr Baratz, MD, DDS, PhD:
“Argument from authority (also known as appeal to authority) is a fallacy of defective induction, where it is argued that a statement is correct because the statement is made by a person or source that is commonly regarded as authoritative. The most general structure of this argument is:

 * Source A says that p is true.
 * Source A is authoritative.
 * Therefore, p is true.

This is a fallacy because the truth or falsity of a claim is not related to the authority of the claimant, and because the premises can be true, and the conclusion false (an authoritative claim can turn out to be false). It is also known as argumentum ad verecundiam (Latin: argument to respect),argumentum ad potentiam (Latin: argument to power), or ipse dixit (Latin: he himself said it).”
Even a cursory evaluation of the science underlying IPT/IPTLD reveals that all cancer cells studied have, not only many more insulin receptors on their surfaces, but that those receptors have up to a 60% greater affinity (stickiness) than usual insulin receptors on non-cancerous cells. Also, what becomes clear from an earnest evaluation of the research into this matter is that there is a 43% homology between insulin receptors and IGF-1 receptors. This aspect of receptor status regarding cancerous cells is an additionally, rather salient aspect of how it is that IPT/IPTLD works to target cancerous cells as well as increase the effectiveness of the chemotherapeutic agent(s) administered. Under these conditions, lower administered doses carry equal, if not more of a “punch.” IGF-1 receptors, once activated, initiates cells to begin dividing, which is a stage of the cell cycle wherein cells are more vulnerable, hence more easily and effectively eliminated. Although cancerous cells have an autocrine function (produce their own insulin and IGF=1), this is occurring at all times which stimulates and fuels their growth during all phases of the cell cycle. However, when this is purposely activated during treatment with a cytotoxic agent, there is greater destruction of the malignant cells being targeted.
Any physician who has worked in an emergency department knows that when a patient arrives in an unconscious condition, the standard protocol usually calls for a dose of naltrexone and a dose of glucose. The naltrexone to counteract opiate overdose and the glucose counteract insulin overdose. The protocol requires both of these agents since there is no information regarding how the person became unconscious. When glucose is administered intravenously (IV) to someone who is suffering from an insulin overdose, they quickly begin to regain consciousness and are often confused, wondering where they are and how they got there. In the vast majority of cases, the person who was “comatose” (unconscious) from insulin having produced a potentially lethal hypoglycemic state returns to normal with no long term, adverse effects. Although the duration that the person was “comatose” is never precisely known, clearly, it must have included, at least a few minutes prior to the ambulance’s arrival plus the duration of the ambulance ride to the ER.
With insulin potentiation therapy (IPT/IPTLD), no one is ever allowed to become, even slightly neurologically impaired and, of course never allowed to lose consciousness. IV glucose is administered immediately if even the slightest neurological impairment becomes evident, e.g., slurred speech and glucagon is available to be used if the glucose does not immediately reverse the condition. Although glucagon is always available, it has never been necessary to use it. Glucagon is a hormone like insulin, produced in the pancreas by the Islets of Langerhans cells. Insulin is produced by the beta cells while glucagon is produced by the alpha cells. They are the ‘yin and yang’ of blood glucose homeostasis. Glucagon has the opposite effect of insulin and therefore, is its natural ‘antidote.’ NO ONE HAS EVER DIED FROM INSULIN POTENTIATION THERAPY. The same cannot be said of conventionally delivered, high dose chemotherapy. As indicated previously, even a cursory evaluation of the protocols used in IPT/IPTLD make it clear that this concern discussed in Blogs like Quack Watch, Moss Reports regarding the potential neurological impairment resulting from acute hypoglycemia brought about by insulin from this therapeutic modality could never occur if one follows the established protocols.
Why have there been no clinical trials using insulin potentiation therapy? As is commonly known, most clinical trials are expensive and funded by pharmaceutical companies attempting to receive FDA approval for use of a drug or device. No pharmaceutical company has to date accepted the offer to fund a clinical trial utilizing IPT/IPTLD nor even attempted to develop a clinical trail in order to prove that one can use 90% less of a chemotherapeutic drug that has already received FDA approval for its use. The stockholders simply would not allow this. It would not be considered a fiscally sound use of corporate money. The only human trail was performed in Uruguay and funded by the government (reference included). The lead investigator, Dr Lasalvia, is a well respected member of the American Society of Clinical Oncology and the results of his small trail clearly demonstrated that insulin plus a lower dose of a chemotherapeutic agent was more effective than either the drug alone or insulin alone. Although there are similar trials being performed in other countries where funding can be obtained from sources other than pharmaceutical companies, none of the studies have been concluded at this time.
In conclusion, IPT/IPTLD has been used successfully since 1930. Since 1997 it was introduced to many countries for neurological infectious, other infectious diseases, i.e., Lymes, and cancer of almost every type, and all stages (I – IV). With this long history of successful use of a modality to deliver drugs in a targeted fashion, minimal side effects (toxicities) and with no deaths, it is truly a human tragedy that this modality has not been evaluated here in the United States beginning with animal models and progressing to humans, as do all of the drugs that receive FDA approval. To merely criticize and attempt to dissuade further evaluation of something with such great potential benefit to humans is not only a tragedy but should be an embarrassment to the scientific community at large.

How very easy it is to proclaim your self a “medical writer or critic” and think you can rule a lifetime legacy as “quackery”. These ignorant “critics” do a couple of Google searches, a few hour research on an 8-decade tradition and actually believe they are experts in the theme.
What a truly pathetic existence they must have.

The good name of my grandfather and my father have been under attack for decades now, attack on my protocol “Insulin Potentiation Therapy” and this will be tolerated no more.

Self proclaimed medical writers that abuse of their (?) prestige, like Robert Baratz, Jonathan Jones and Ralph W Moss, come out!
They have been attacking my lifetime work and placing doubt over the effectiveness of IPT©- IPTLD® with no solid foundation, except non-medical opinions. But these are the “low blows” of a coward, who attacks behind comfortable desks and think they can undo a lifetime achievement from a laptop and steal a life saving treatment to cancer patients.

The testimony of IPT©- IPTLD® s effectiveness is living and breathing in every cancer patient that lives today in remission, beating in every healthy patient worldwide who overcame cancer when no other doctor gave them hope. IPT©- IPTLD® is hope and mere verbal attacks from you ignorant selfish people, who have no courage to tell it to my face, can undo. My office is open for discussion with you “Quackery Cowards” and dare to say these things to my face. I am not hiding like you are.

Unlike you people, I do have moral standards and courage to fight my opponents out in the open. I do not hide behind comfortable desks, I don’t offend or attack other professional’s based on Google searches and post whatever comes to mind. You are dealing with human lives, and they have the right to know TRUTH, and the TRUTH is that IPT©- IPTLD® is a successful alternative cancer treatment, proven for decades to save patients lives. The theoretical proof is here in my office, if you want it, come and get it! Stop tainting my family’s good name and stop poisoning peoples mind with LIES, take a stand and come out you Cowards! You’ve done enough damage. Think you know more about IPT? PROVE IT!

Publications and Essays on IPT, also Supportive Studies – Published clinical and in-vitro studies that support the use of  insulin as a biologic response modifier.

1)Poster Presentation at the Third Annual Comprehensive Cancer Management Conference, Washington, DC June 2000
Primary Breast Conserving Treatment for Breast Cancer Using Biologic Response Modification with Insulin in Combination with Non-Toxic Low-Dose Chemotherapy. Steven G. Ayre, M.D.

2)Insulin Shows Promise
Oncology News, 1991, 17(4):1,7

3) Ayre SG, Perez Garcia y Bellon D, Perez Garcia Jr D.  Neoadjuvant low-dose chemotherapy with insulin in breast carcinomas.  Eur J Cancer. 26:1261-2, 1990

4) Ayre SG, Perez Garcia Y Bellon D, Perez Garcia Jr D.  Insulin potentiation therapy:  a new concept in the management of chronic degenerative disease.  Medical Hypotheses 20:199-210, 1986

5) Lippman ME, Dickson RB, Kasid A, et al.  Autocrine and paracrine growth regulation of human breast cancer.  J Steroid Biochem 24:147-154, 1986

4) Hilf R.  The actions of insulin as a hormonal factor in breast cancer.  In:  Pike MC, Siiteri PK, Welsch CW, eds.  Hormones and Breast Cancer, Cold Spring Harbor Laboratory, 1981, 317-337.

6) Cullen JK, Yee D, Sly WS, et al.  Insulin-like growth factor receptor expression and function in human breast cancer.  Cancer Res 50:48-53, 1990

6) Holdaway IM, Freisen HG.  Hormone binding by human mammary carcinoma.  Cancer Res 37:1946-1952, 1977

7) Papa V,  Pezzino V, Constantino A, et al.  Elevated insulin receptor content in human breast cancer.  J Clin Invest 86:1503-1510, 1990

8) Sporn MB, Todaro GJ.  Autocrine secretion and malignant transformation of cells.  N Engl J Med 308:487-490, 1980

9) Jaques G, Rotsch M, Wegmann C, et al.  Production of immunoreactive insulin-like growth factor 1 and response to exogenous IGF-1 in small cell lung cancer cell lines.  Exp Cell Res 176:336-343, 1988

10) Nakanishi Y, Mulshine JL, Kasprzyk PG, et al.  Insulin-like growth factor-1 can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.  J Clin Invest 82:354-359, 1988

11) Lee PDK, Rosenfeld RG, Hintz RL, Smith SD.  Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts.  J Clin Endocr Metab 62:28-35, 1986

12) Colman PG, Harrison LC.  Structure of insulin/insulin-like growth factor-1 receptors on the insulinoma cell, RIN-m5F.  Biochem Biophys Res Commun 124:657-662, 1984

13) Zapf J, Froesch ER.  Insulin-like growth factors/somatomedins:  structure, secretion, biological actions and physiological role.  Hormone Res 24:121-130, 1986

14) Papa V, Constance CR, Brunetti A, et al.  Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinomas.  Cancer Res 50:7857-7862, 1990

15) Stewart AJ, Johnson MD, May REB, Westley RB.  Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells.  J Biol Chem 265:21172-21178, 1990

16) Eppenberger U.  New aspects in the molecular growth regulation of mammary tumors.  In:  Eppenberger U, Goldhirsch A, eds.  Recent Results in Cancer Research, Vol. 113:  Endocrine Therapy and Growth Regulation of Breast Cancer.  Berlin-Heidelberg, 1989, 1-3

17) DeLeon DD, Bakker B, WIlson RL, et al.  Demonstration of insulin-like growth factor (IGF-I and IGF-II) receptors and binding protein in human breast cancer cell lines.  Biochem Biophys Res Commun 152:398-405, 1988

18) Karey KP, Sirbasku DA.  Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17B-estradiol.  Cancer Res 48:4083-4092, 1988

19) King GL, Kahn CR, Rechler MM, Nissley SP.  Direct demonstration for separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulin-like growth factor) using antibodies to the insulin receptor.  J Clin Invest 66:130-140, 1980

20) Jacobs S, Cook S, Svoboda M, Van Wyk JJ.  Interaction of the monoclonal antibodies alpha-IR-1 and alpha-IR3 with insulin and somatomedin-C receptors.  Endocrinol 118:223-226, 1986

21) Goustin AS, Leof EB, Shipley GD, Moses HL.  Growth factors and cancer.  Cancer Res 46:1015-1029, 1986

22) Unterburger P, Sinop A, Noder w, et al.  Diabetes  mellitus  and  breast  cancer:  a retrospective follow-up study.  Onkologie 13:17-20, 1990

23) Yee D, Palk S, Lebovic GS, et al. Analysis of insulin-like growth-factor I gene expression: evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509-517, 1990

24) Hilf R.  Primary and permissive actions of insulin in breast cancer.  In:  Leung BS, ed.  Hormonal regulation of mammary tumors.  Montreal, Eden Press, 1982, Vol. 2, 123-137

25) Alabaster O, Vonderhaar BK, Shafie SM.  Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 human breast cancer cells.  Eur J Cancer Clin Oncol 17:1223-1228, 1981

26) Oster JB, Creasey WA.  Enhancement of cellular uptake of ellipticine by insulin preincubation.  Eur J Cancer Clin Oncol 17:1097-1103, 1981

27) Schilsky RL, Bailey BD, Chabner BA.  Characteristics of membrane transport of methotrexate by cultured human breast cancer cells.  Biochem Pharmacol 30:1537-1542, 1981

28) Shinitzky M, Henkart P.  Fluidity of cell membranes – current concepts and trends.  Int Rev Cytol 60:121-147, 1971

29) Jeffcoat R.  The biosynthesis of unsaturated fatty acids and its control in mammalian liver.  Essays Biochem 15:1-36, 1979

30) Gasparro FP, Knobler RM, Yemul SS, Bisaccia E, Edelson RL.  Receptor mediated photo-cytotoxicity:  synthesis of a photoactivatable psoralen derivative conjugated to insulin.  Biochem Biophys Res Comm 141:502-209, 1986

31) Poznansky MJ, Singh R, Singh B.  Insulin:  carrier potential for enzyme and drug therapy.  Science 223:1304-1306, 1984

32) Ayre SG.  New approaches to the delivery of drugs to the brain.  Med Hypotheses 29:283-291, 1989

33) Gross GE, Boldt DH, Osborne CK.  Perturbation by insulin of human breast cancer cell kinetics.  Cancer Res 44:3570-3575, 1984

34) Paridaens R, Klijn JGM, Julien JP, et al.  Chemotherapy with estrogenic recruitment in breast cancer:  experimental background and clinical studies conducted by the EORTC breast cancer cooperative group.  Eur J Cancer Clin Oncol 22:728, 1986

35) Van der Burg B, de Laat SW, van Zoelen EJJ.  Mitogenic stimulation of human breast cancer cells in a growth-factor defined medium:  synergistic action of insulin and estrogens.  In:  Brescani F, King RGB, Lippman ME, Raynaud JP, eds.  Progress in Cancer Research and Therapy, vol. 35:  Hormones and Cancer 3.  New York, Raven Press, Ltd.  1988, 231-233.

36) Goldfine ID, Purello F, Vigneri R, and Clawson GA.  Direct regulation of nuclear functions by insulin:  relationship to mRNA metabolism.  In:  Czech MP, ed. Molecular Basic of Insulin Action.  New York, Plenum Press, 1985, 329-345.

37)Blood Brain Barrier Passage of Azidothyumidine in Rats: Effects of Insulin
Steven G. Ayre (1), Brian Skaletski (2) and Aron D. Mosnaim( 2).
Research Communications in Chemical Pathology and Pharmacology JANUARY 1989 VOL.63, NO. 1. Departments of Family Medicine and Pharmacology and Molecular Biology , University of Health Sciences/The Chicago Medical School, North Chicago, IL 60064.

38)New Approaches to Delivery of Drugs to the Brain. S.G. Ayre. Medical Hypotheses 29:283-291, 1989

39)Insulin, chemotherapy, and the mechanisms of malignancy: the design and the demise of cancer. S.G. Ayre, M.D., D. P. Garcia Bellon, M.D., D. P. Garcia, Jr., M.D. Medical hypotheses 55.4 (2000): 330-334.

40)Low dose chemotherapy in combination with insulin for the treatment of metastatic tumors: C. Damyanov, M. Radoslavova, V. Gavrilov, D. Stoeva. Medical Center of Integrative Medicine, Sofia, Bulgaria. Journal of BUON 14: 711-15, 2009.

41)Insulin Potentiation Therapy in the treatment of malignant neoplastic diseases: a three year study. Damyanov C, Gherasimova DM, Avramov LA, Masley IK (2012). J Cancer Sci Ther 4: 088-091. doi:10.4172/1948-5956.1000117

42)Low-Dose Chemotherapy with insulin (Insulin Potentiation Therapy) in combination with hormone therapy for treatment of castration-resistant prostate cancer. Damyanov, Christo, et al. ISRN urology 2012 (2012).

43)Metabolic Modification by Insulin Enhances Methotrexate Cytotoxicity in MCF-7 Human Breast Cells. Alabaster, O. Vonderhaar, B. and Shafie, S. Eur J Cancer Clin Oncol. Vol 17, No. 11, pp 1223-1228. 1961.

44)Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Lundholm K, Körner U, Gunnebo L, Sixt-Ammilon P, Fouladiun M, Daneryd P, Bosaeus I. Clin Cancer Res. 2007 May 1;13(9):2699 706.

45)Long-Term Effect of Diabetes and Its Treatment on Cognitive Function. Jacobson, Alan, N Engl J Med 2007; 356:1842-52.

46)Preclinical safety and antitumor efficacy of insulin combined with irradiation. Bénédicte F. Jordan, Nelson Beghein, Nathalie Crokart, Christine Baudelet, Vincent Gregoire, Bernard Gallez. Radiotherapy and Oncology 81 (2006) 112–117.

47)Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients. Lasalvio-Prisco, Eduardo, Cancer Chemother Pharmacol (2004) 53: 220–224.

48)The effect of insulin on chemotherapeutic drug sensitivity in human esophageal and lung cancer cells. Zhonghua Yi Xue Za Zhi. 2003 Feb 10;83(3):195-7.

49)Pretreatment with insulin enhances anticancer functions of 5-fluorouracil in human esophageal and colonic cancer cells. Zou K, Ju JH, Xie H. Acta Pharmacol Sin. 2007 May; 28(5):721-30.

50)A pilot study of Auron Misheil Therapy (AMT) in patients with advanced cervical cancer: tumor response and its correlation with clinical benefit response, and preliminary quality of life data.” Scheele, Jürgen, et al. Oncology reports 22.4 (2009): 877-883.

51)Insulin in endometrial carcinoma chemotherapy: A beneficial addition and not a problem. Sha, Huilan, et al. Journal of Huazhong University of Science and Technology [Medical Sciences] 30 (2010): 631-637.

52) Insulin for Everything. TIME magazine April 10, 1944

53)Long-Term Outcomes of the Treatment of Unresectable (Stage III - IV)Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy (MSCT): A Retrospective Study
Mehmet Salih Iyikesici1, Ayshe Slocum2*, Engin Turkmen3, Ovunc Akdemir4, Abdul Kadir Slocum5, Turgut Ipek6, Erhun Eyuboglu6, Ferhan Bulent Berkarda7.

How to get in touch with Donato Perez Garcia, MD.

Mobil phone: 664-228-3367
Assistant Email:

Medical Office
 Consultorio #505. Hospital Angeles Tijuana
Phone: +52-1-(664) 616-4878
Phone: +51-(664) 635-1827
Skype Phone USA: (619) 798-8017

Web pages:

IPT E-Booklet:

Social Network:



YouTube: Patient Testimonials and Educational videos about IPT/IPTLD




Blogs: “IPTLD for Cancer and Chronic Degenerative Diseases Treatment by Donato Perez Garcia, M.D.”

Radio Shows

Donato Perez Garcia, MD.

Friday, July 22, 2016

I no longer have a tumor "cancer" in my left breast. A true story. July 19, 2016.

Can breast cancer be cured and breast preserved. My story is one of joy, success and another prove that the treatment my doctor in Mexico administers is safe and effective. I no longer have a tumor in my left breast. A true story. July 19, 2016.

I'm Alize and I want to share my story. I realized that since 1999 I started to notice that my left breast had a slight feeling of heaviness. I decided to only change my diet and take some herbal remedies. This discomfort remained unchanged until July 2015 at that time it was a more intense heaviness and swelling of the left breast was added. I went to visit my doctor, he recommended to make me tests. A biopsy in August 7, 2015 reported that I had infiltrating ductal carcinoma in the left breast. On September 9, 2015  a PET Scan showed the tumor in the left breast (see photography a yellow red spot in the chest , red circle to show where the tumor was) . In fear for my life as told my the Oncologist I accept to start with standard chemotherapy treatment under the professional care of this traditional oncologist. The first round went wrong, I felt terrible, I had a severe reaction that my life was endangered, they stopped the administration of the drugs. I did not tolerated and decided not to continue with traditional chemotherapy by the end of September of 2015. Next thing to do was to resume natural therapies, substances, vitamin C and other supplements that I was told to try. Although I felt some relief in the breast, the swelling and inflammation did not improve and the tumor started to be felt bigger. Yes I was afraid. In early December of 2015 I was told to seek the opinion of a medical doctor in Mexico with a 33 year experience in a targeted medical treatment that has helped many patients. So I went ahead and first visited his website ( and decided to try, why not, nothing to lose and no other choices to follow. The first consultation he gave me was on January 8, 2016 where he reviewed my case and my physical condition. It was not until February 4, 2016 that he could give me the first appointment to begin treatment. I followed his instructions, took all his prescription medicines, received his IV targeted low dose chemotherapy or IPTld with minimal side effects, all well tolerated, no hair loss, no nausea. Of course I had my doubts, I heard unfavorable comments. I thought I would have to end up in an operating room to have a mastectomy feeling mutilated, but if this treatment did not work for me it is my life. I did not expect to see my doctor to be supervising my treatments, listening to me, was a good experience because I felt this doctor cares yes Dr. Donato Perez Garcia was always overseeing my treatment and on Friday 24 of June 2016 it was the last treatment he administered to me. He said you need to schedule and appointment to have your 2nd PET Scan to assess the outcome of  my IPT/IPTLD treatment. On July 19, 2016 they gave me the PET Scan results. I am going to keep my left breast, no need for a surgical intervention and yes there is no tumor in the left breast. It seems incredible, tears of emotion, tears of joy and gratitude to Dr Donato Perez Garcia. I know I'm not your first patient in remission there are many and from around the earth (no exaggeration) I feel happy, I got my life back. In his website I read the story of another if his patients Annie Brandt and I never taught that I will be in the same situation, cancer free, breast preserved, got my life and emotions back. Thank you Dr. Donato Perez Garcia, MD. Below are the PET Scan from September 2015 and from July 2016. Inside the red circle a yellow red spot, the tumor as it looked in September of 2015 and an empty red circle in July of 2016. It is real, it's true and it works.

 This is my PET Scan from September 9, 2015, inside the red circle a bright yellow/red spot is seen, this is the tumor my cancer.

 This is my recent PET Scan from July 19, 2016, inside of the red circle no spot can be seen, I no longer have a tumor, my cancer is now in remission. Thanks to Doctor Donato Perez Garcia, MD and his IPT treatment a targeted chemotherapy protocol that delivers chemo drugs just inside of the cancerous cells. This is true. Here is the evidence that in 5 months I recovered my life, my happiness, my joy, and not mutilated. This therapy is targeting chemotherapy to the cancer cells.

July 19, 2016.

Tuesday, July 5, 2016

IPTLD® work for Other Chronic Illnesses?

Donato Perez Garcia
Hospital Angeles Tijuana B.C.
IPT® (Insulin Potentiation Therapy)

A chronic degenerative disease occurs when the function or structure of the affected tissues or organs will progressively deteriorate over time, whether due to normal bodily wear or lifestyle choices such as exercise or eating habits.
IPT® can stop the damage and for some diseases provide good quality of life and prolong periods without symptoms.

Thursday, June 9, 2016


Donato Perez Garcia
Hospital Angeles Tijuana B.C.
IPT® (Insulin Potentiation Therapy)

                                    IF IPT® USES INSULIN, IS IT SAFE?

YES. IPT® is a safe procedure, WHEN ADMINISTERED BY A TRAINED, CERTIFIED IPT®PHYSICIAN. The amount of insulin used in this procedure is very low and will not cause damage to your body. A minor state of hypoglycemia is induced to achieve the precise “therapeutic moment” when the body is at it’s best to receive medication. Feel confident that you’re in the hands of Dr. Donato Pérez García, the most experience IPT® doctor who’s been doing this for over 30 years. No patient has ever dyed while undergoing this protocol.

Thursday, May 26, 2016

IPTLD vs Cancer

 Dr.Donato Perez Garcia

Hospital Angeles Tijuana




IPTLD vs Cancer

It all starts with insulin; a hormone produced in the pancreas that regulates metabolism of carbohydrates, fat and excess glucose from the blood. But it has many more functions on a cellular level.
With a single shot, IPTLD® uses insulin to modify cancer cells molecular biology. It targets the cancerous cell. The cell “wakes up” with a tremendous appetite.  Insulin opens up the cancerous cell membrane, making it vulnerable and receptacle to any substance it encounters. One by one, they all start searching for food. During that precise moment, we inject all Chemo Drugs. Since the dosage is 70% less than regular chemo sessions, the non affected cells are left intact, avoiding side effects. And because it changes the biochemical compounds of the cell, it also serves as detoxification.
We feed the cancerous cell with chemo.
Cancer cells take in the chemotherapy drugs much more easily with insulin; it potentiates medication, transporting it more effectively into the cells.
Insulin Potentiation Therapy Low Dose® changes the   bio-physic-chemical constants and parameters of the blood, attacking first the cancerous cell through its intra-extra cellular environment, causing permeability in the cell’s membrane.
In other words, insulin makes the cancer cells hungry for food (sugar) and in this state gobbles up everything you put into it, even chemo drugs, causing its death.
One by one, cancer cells diminish in the affected tissue. Until they all die. Healthy cells remain intact. Allowing white cells to clean the entire system. Promoting and strengthening your immune system, protecting you from any carcinogenic agent. Because people respond differently to similar chemo drugs and other prescription drugs including insulin, very few have allergic reactions such as fast heartbeat, low blood pressure, itching, or rash; reactions that do not endanger life and can be safely reversed with the appropriate medication.


Monday, May 16, 2016

 Dr.Donato Perez Garcia

Hospital Angeles Tijuana




The Best of I.P.T. and Functional Oncology now as ONE Team

As of this month, I.P.T. is now officially part of the Functional Oncology team at Angeles Health International. Together, they are building a cutting edge cancer treatment program that combines the best of Functional I.P.T. and Functional Medicine Therapies.
As Head director of Insulin Potentiation Therapy, Dr. Donato Pérez García is now in alliance with Head director of the Functional Oncology Team, Dr. Ariel Pérez, together they combine, both experience and the functional approach, offering the best cancer care treatment, plus a 3 year follow up plan to all our patients.
It’s the best of I.P.T. and Functional Oncology – combined-
Functional Oncology Team

Wednesday, January 13, 2016



First of all I want to thank God for inspiring Dr. Donato to uphold his family legacy.
This is not an easy task for him. I really admire him for his compassion and caring for his patients with the highest integrity. I’m now 50 years old and I’ve been to many doctors in my life time and I can say Dr. Donato is one of the most honest doctors I’ve ever met.

I am under treatment with Dr. Donato now for 8 months for my breast cancer, there are good moments and bad moments but I know that Dr. Donato is the right person to make me heal, the method that he uses does not make me ill, like nausea or loss of hair or any other side effects that one might experience with the traditional chemotherapy. I do have some body aches and pains but not from the chemo.

The techniques that he and his family developed is considered world class medicine and I don’t understand why doctors in the USA do not want to adopt this type of methodology. If there was a safer less harmful way to heal the patient, that should be adopted with no reservation.

My journey through this dealing with cancer
I was diagnosed April 7th 2014 with stage 2 cancer, it caused quite a big blow to my psyche because I’m not the type of person that should get cancer. I’ve been taking care of myself of what should and shouldn’t do in terms of health, I’m very focused and clear in mind so with this news, it really just … my hole world just fell in front of me. At the time I didn’t know what to do, the doctors in USA are pushing towards surgery, chemo and radiation. I rapidly learned what this disease is all about and I wanted to find and alternative to these 3 methods, since these choices may harm the patient more than what they really help, so therefore I refuse to take all those treatments and search for holistic methods like herbal medicine, nutritional therapy, etc. Unfortunately my cancer was too agressive , nothing holistic that was shown to heal patients from their cancer would heal me, my cancer would keep growing and growing as the months went by. So I had to consider other methods, other alternative methods in treating cancer and there are many out there like oxygen therapy and all the other ones., hyperthermia and UV therapy (I don’t know what else there called) and I’ve decided to do Insulin Potentiation Therapy (IPT) because I feel that IPT has a longer track record and a very vanguard method.
So my search for the right IPT doctor to perform this, lead me to Dr. Donato. By the time I went to see him at his office in Mexico, in march 31st of 2015, my cancer had spread to stage 4. By then, the pain became more and more severe, I could not even walk or do any type of shores because the level of pain (a level 10).

When I started treatment with Dr. Donato my pain began to subside, I was able to walk like a normal person, however after 3 months of treatment my cancer continued to grow, and this time it’s restricting my range of motion and causing the edema in my arm. And again the pain returned and my intake of pain medication also tripled. And yet, it does not relief the pain.

HOW DO I DEAL WITH THE PAIN? I deal with the pain, sleeping it off, or walk or just sit up, and plead to God to help me and be strong, and to overcome this unavoidable experience. The initial pain before treatment was from the cancer spreading, this pain after/during treatment is caused by the breakdown of the tumor. So I just have to remind myself that I am healing and this pain will diminish as the tumor shrinks.

This process is not fast, and I leave that, if one does have a positive outlook every day, one can overcome this torturous… something…feeling?

I have full faith and confidence in Dr. Donato work, and will continue to get treatments from him until I am cancer free. In the mean while I will have to find other alternatives to killing my pain.

Spiritually I’ve became more calm, and being able to detach myself, knowing that if for any reason my journey on earth should end, I will be at peace with that.  I do not know what God’s plans are for me, and why I should be experiencing this type of “path”. So I will have to be patient and take it day by day until he reviews his-her intention.

Evaluate every method carefully, don’t rush yourself into a method that perhaps may not be right for you. I was willing to wait until stage 4 before I took action, cancer will not kill you so quickly, you have time to evaluate all options and the most important thing is finding a doctor that will listen to you, your concerns and who is not looking at how deep your pocket is but a doctor that really cares about your survival.
Cancer patients do go through very tough times, sometimes they don’t even show you, because they want to be strong in front of you. Be kind and gentle and give as much financial and emotional support to heal the patient as much as possible. With an illness as cancer, expenses will be overwhelmingly high, expect that.

I believe that we are all here for a purpose and our journey—our goal in life should be attaining happiness, and it’s that simple.  Everything you do every day, just ask yourself if you are happy today. There are people who make life very complicated, and shouldn’t have to be that way. Pull yourself away from your daily living, ignore things that are considered bad to you, pull yourself away as if you where dealing your situation through a TV screen; things are happening in front of you but through a TV screen and that’s how you can detach from the situation. For instance if someone where to scream at you, your reactions would be to defend yourself and instead of doing that you would stand back and look at this person and ask yourself why is this person so angry? Did this person went through a bad day? And that’s why he yells at me and when you train yourself to not be reactive then slowly you will have clarity of mind under stressful situations.

And know that this will not be the only lifetime living, there are some religions that say you don’t have another life time and it spreads fear among the people it does not matter what religion you believe in, but if you adopt some ideology that will give you peace of mind, that will give you the goal to be living and eventually dying is to attain certain teachings and as I said again, the final goal for us humans, is to learn how to live a happy life, despite of whatever is going on around us.

Madam Q.

For more information on IPT Therapies:

Hospital Angeles Tijuana
Paseo de los Héroes # 10999, Tijuana, B.C. 22010
Medical Tower
5th Floor Office 505
U.S. 619-798-8017
Mexico: 52+664-635-1827
Office Business hours:
Monday through Friday (Pacific Standard Time GMT-8)
9:00 am - 3:00 pm